Results At 1 year, patients achieved significant weight loss with a median total weight loss (%TWL) of 25.5% and a median excess weight loss (%EWL) of 66.3% compared to 16.6% and 40.8%, respectively, at treatment initiation with BMI reduction of 3.7 kg/m 2
Not suitable for patients with cardiac conditions or those taking medications that prolong the QT interval or strong CYP3A4 inhibitors
If you have a thin skin, smaller filler sizes are best used to avoid visible lumps or irregularities, while a thick skin can comfortably accommodate larger filler sizes
the same would apply to a woman using a combined oral preparation, as any reduction in efficacy would apply equally to the oestrogen and the progestogen and so not increase the risk of endometrial proliferation
For men, its often fatigue, low drive, or weight gain tied to declining testosterone
Semaglutide works through that same pathway, which is one reason it can support weight loss more biologically